Therefore, the nuclear localization of AKT, EGFR, and MDM2, and the exclusion of nuclear FOXO3a, have been linked with enhanced drug resistance, poor prognosis, and unfavorable overall survival in various cancers [22,45,46,47,48]. Here, AKT1 is linked to cancer.